Krish S. Krishnan, President and CEO at Krystal Biotech, Inc. (KRYS), sold 95,300 shares at $105.06 ($10.1M) on 2023-12-11, disclosed to the SEC on 2023-12-12.
Scheduled sale ($10.1M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $104.26 | 2,854 | $298K | 3.0% |
| 2 | $104.26 | 2,854 | $298K | 3.0% |
| 3 | $104.41 | 4,400 | $459K | 4.6% |
| 4 | $105.06 | 4,541 | $477K | 4.7% |
| 5 | $105.06 | 4,541 | $477K | 4.7% |
| 6 | $105.50 | 6,263 |
| $661K |
| 6.6% |
| 7 | $105.50 | 6,263 | $661K | 6.6% |
| 8 | $106.04 | 17,505 | $1.9M | 18.4% |
| 9 | $106.04 | 17,505 | $1.9M | 18.4% |
| 10 | $106.11 | 14,237 | $1.5M | 15.0% |
| 11 | $106.11 | 14,237 | $1.5M | 15.0% |
| 12 | $107.66 | 100 | $11K | 0.1% |
| Total | $105.72 avg | 95,300 | $10.1M | 100% |
| Filing → |
| KRYS | SELL | 2026-03-06 | $13.2M | — | Filing → |
| KRYS | SELL | 2025-12-05 | $20.9M | — | Filing → |
| KRYS | SELL | 2025-07-16 | $10.1M | — | Filing → |